Shares of TNF Pharmaceuticals (NASDAQ:TNFA) climbed 5% following the announcement that the company has secured exclusive global rights to a pioneering light-based computing accelerator for cryptocurrency applications.
The company entered into a licensing agreement with LightSolver Ltd. for its laser-based processing unit (LPU) technology, designed to execute compute-intensive operations far faster than conventional GPUs and high-performance computing systems. TNF also plans to rebrand to reflect this new strategic direction.
According to TNF, LightSolver’s technology could cut energy costs for crypto operations by up to 90%, potentially providing a more environmentally friendly approach to blockchain and mining activities. The system operates without vacuum chambers or ultracold conditions and fits within a standard rack unit.
“Our new partnership with LightSolver gives us exclusive access to quantum-inspired LPU-based systems capable of unlocking unprecedented performance and sustainability for the cryptocurrency industry,” said Joshua Silverman, TNF’s Executive Chairman.
In addition, TNF announced a $7 million private placement, including participation from its largest strategic investor. The company is selling 7,000 shares of newly created Series H convertible preferred stock at $1,000 per share, convertible into common stock at an initial rate of $5.00 per share.
LightSolver, co-founded by PhD physicists from the Weizmann Institute of Science, was recognized by the World Economic Forum as a 2025 Technology Pioneer and listed in Gartner’s 2025 Hype Cycle for Data Center Infrastructure Technologies.
TNF also confirmed it is evaluating options for its existing pharmaceutical platforms, including its oral TNF-alpha inhibitor and Supera-CBD products.
TNF Pharmaceuticals stock price
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.